chandonium iodide: structure
ID Source | ID |
---|---|
PubMed CID | 71537 |
CHEMBL ID | 2106112 |
SCHEMBL ID | 12506217 |
MeSH ID | M0049817 |
Synonym |
---|
chandonium iodide |
hs-310 |
candocuronium iodide |
CHEMBL2106112 |
17a,17a-dimethyl-3beta-(1-methylpyrrolidinio)-17a-azonia-d-homoandrost-5-ene diiodide |
17a-methyl-3-beta-pyrrolidino-17a-aza-dihomoandrost-5-ene dimethiodide |
17a-azonia-d-homoandrost-5-ene, 17alpha,17alpha-dimethyl-3-(1-methylpyrrolidinio)-, diiodide, (3beta)- |
unii-sc80gnp08c |
candocuronium iodide [inn] |
hs 310 |
sc80gnp08c , |
17a,17a-dimethyl-3.beta.-(1-methylpyrrolidinio)-17a-azonia-d-homoandrost-5-ene diiodide |
SCHEMBL12506217 |
Q5032016 |
DTXSID60969306 |
Timeframe | Studies, This Drug (%) | All Drugs % |
---|---|---|
pre-1990 | 8 (80.00) | 18.7374 |
1990's | 2 (20.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] |
According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be strong demand-to-supply ratio for research on this compound.
| This Compound (37.83) All Compounds (24.57) |
Publication Type | This drug (%) | All Drugs (%) |
---|---|---|
Trials | 2 (18.18%) | 5.53% |
Reviews | 0 (0.00%) | 6.00% |
Case Studies | 0 (0.00%) | 4.05% |
Observational | 0 (0.00%) | 0.25% |
Other | 9 (81.82%) | 84.16% |
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] |